Human monoclonal antibodies to Ara h 2 inhibit allergen-induced, IgE-mediated cell activation
Sumei Liao
Division of Allergy and Clinical Immunology, Departments of Medicine and Immunology, University of Colorado Denver, Aurora, Colorado
Search for more papers by this authorSarita U. Patil
Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, The Food Allergy Center, Boston, Massachusetts
General Hospital and MassGeneral Hospital for Children, Boston, Massachusetts
Search for more papers by this authorWayne G. Shreffler
Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, The Food Allergy Center, Boston, Massachusetts
General Hospital and MassGeneral Hospital for Children, Boston, Massachusetts
Search for more papers by this authorStephen C. Dreskin
Division of Allergy and Clinical Immunology, Departments of Medicine and Immunology, University of Colorado Denver, Aurora, Colorado
Search for more papers by this authorCorresponding Author
Xueni Chen
Division of Allergy and Clinical Immunology, Departments of Medicine and Immunology, University of Colorado Denver, Aurora, Colorado
Correspondence
Xueni Chen, Division of Allergy and Clinical Immunology, University of Colorado Denver, Campus Box B164, 12700 E. 19th Ave., Room 10002, Aurora, CO 80045.
Email: [email protected]
Search for more papers by this authorSumei Liao
Division of Allergy and Clinical Immunology, Departments of Medicine and Immunology, University of Colorado Denver, Aurora, Colorado
Search for more papers by this authorSarita U. Patil
Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, The Food Allergy Center, Boston, Massachusetts
General Hospital and MassGeneral Hospital for Children, Boston, Massachusetts
Search for more papers by this authorWayne G. Shreffler
Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, The Food Allergy Center, Boston, Massachusetts
General Hospital and MassGeneral Hospital for Children, Boston, Massachusetts
Search for more papers by this authorStephen C. Dreskin
Division of Allergy and Clinical Immunology, Departments of Medicine and Immunology, University of Colorado Denver, Aurora, Colorado
Search for more papers by this authorCorresponding Author
Xueni Chen
Division of Allergy and Clinical Immunology, Departments of Medicine and Immunology, University of Colorado Denver, Aurora, Colorado
Correspondence
Xueni Chen, Division of Allergy and Clinical Immunology, University of Colorado Denver, Campus Box B164, 12700 E. 19th Ave., Room 10002, Aurora, CO 80045.
Email: [email protected]
Search for more papers by this author
CONFLICT OF INTEREST
The authors declare no conflict of interest.
Supporting Information
| Filename | Description |
|---|---|
| cea13442-sup-0001-FigS1.tiffimage/tif, 24.1 MB | |
| cea13442-sup-0002-FigS2.tiffimage/tif, 9.5 MB | |
| cea13442-sup-0003-FigS3.tiffimage/tif, 14.4 MB | |
| cea13442-sup-0004-FigS4.tiffimage/tif, 9.6 MB | |
| cea13442-sup-0005-FigS5.tiffimage/tif, 3.9 MB | |
| cea13442-sup-0006-FigS6.tiffimage/tif, 2.7 MB | |
| cea13442-sup-0007-FigS7.tiffimage/tif, 3.9 MB | |
| cea13442-sup-0008-FigS8.tiffimage/tif, 4.8 MB | |
| cea13442-sup-0009-Supinfo.docxWord document, 1.4 MB |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Jones SM, Pons L, Roberts JL, et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol. 2009; 124(2): 292–300, e1–97.
- 2Burks AW, Jones SM, Wood RA, et al. Oral immunotherapy for treatment of egg allergy in children. N Engl J Med. 2012; 367(3): 233–243.
- 3Koppelman SJ, Wensing M, Ertmann M, Knulst AC, Knol EF. Relevance of Ara h1, Ara h2 and Ara h3 in peanut-allergic patients, as determined by immunoglobulin E Western blotting, basophil-histamine release and intracutaneous testing: Ara h2 is the most important peanut allergen. Clin Exp Allergy. 2004; 34(4): 583–590.
- 4Palmer G, Dibbernjr D, Burks A, et al. Comparative potency of Ara h 1 and Ara h 2 in immunochemical and functional assays of allergenicity. Clin Immunol. 2005; 115: 301–312.
- 5Kulis M, Chen X, Lew J, et al. The 2S albumin allergens of Arachis hypogaea, Ara h 2 and Ara h 6, are the major elicitors of anaphylaxis and can effectively desensitize peanut-allergic mice. Clin Exp Allergy. 2012; 42(2): 326–336.
- 6Handlogten MW, Kiziltepe T, Serezani AP, Kaplan MH, Bilgicer B. Inhibition of weak-affinity epitope-IgE interactions prevents mast cell degranulation. Nat Chem Biol. 2013; 9(12): 789–795.
- 7Patil SU, Ogunniyi AO, Calatroni A, et al. Peanut oral immunotherapy transiently expands circulating Ara h 2–specific B cells with a homologous repertoire in unrelated subjects. J Allergy Clin Immunol. 2015; 136(1): 125–134 e12.
- 8Hoh RA, Joshi SA, Liu YI, et al. Single B-cell deconvolution of peanut-specific antibody responses in allergic patients. J Allergy Clin Immunol. 2016; 137(1): 157–167.
- 9Orengo JM, Radin AR, Kamat V, et al. Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement. Nat Commun. 2018; 9(1): 1421.
Citing Literature
